Concepedia

Xiuyan Wang

XW

Statistics

Publications

101

Citations

13.9K

H-Index

41

Active since

1987

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Dalian Institute of Chemical Physics

Chinese Academy of Sciences

Cornell University

Tongji University

Xiuyan Wang is an author at Memorial Sloan Kettering Cancer Center specializing in life sciences, immunotherapy, and cancer immunotherapy.

ORCID

Publications per year

1987–2024

101

Publications

101

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

Jae H. Park, Isabelle Rivière, Mithat Gönen et al. · New England Journal of Medicine · 2018 · 2.7K citations · Full text

, , +17

CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia

Renier J. Brentjens, Marco L. Davila, Isabelle Rivière et al. · Science Translational Medicine · 2013 · 2.1K citations · Full text

, , +13

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

Renier J. Brentjens, Isabelle Rivière, Jae H. Park et al. · Blood · 2011 · 1.3K citations · Full text

, , +11

CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape

Mohamad Hamieh, Anton Dobrin, Annalisa Cabriolu et al. · Nature · 2019 · 656 citations · Full text

, , +14

A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab

Prasad S. Adusumilli, Marjorie G. Zauderer, Isabelle Rivière et al. · Cancer Discovery · 2021 · 560 citations · Full text

, , +17

1–5 of 101